Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,049 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $392.82 | 6 | $0 (2024) |
| ABBVIE INC. | $299.11 | 15 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $170.30 | 8 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $77.06 | 4 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $46.37 | 1 | $0 (2023) |
| Averitas Pharma Inc. | $22.60 | 1 | $0 (2023) |
| SI-BONE, INC. | $14.00 | 1 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $13.92 | 1 | $0 (2022) |
| Acorda Therapeutics, Inc | $13.14 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $581.01 | 21 | Medtronic, Inc. ($244.55) |
| 2023 | $412.56 | 14 | Medtronic, Inc. ($148.27) |
| 2022 | $55.75 | 3 | Scilex Pharmaceuticals Inc. ($24.30) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Analgesic | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | Medtronic, Inc. | ACTIVOS 10 BONE CEMENT (Device) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 10/22/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/28/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/31/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.25 | General |
| Category: Opioid Analgesic | ||||||
| 05/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Analgesic | ||||||
| 05/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Analgesic | ||||||
| 04/16/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $171.87 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/27/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/22/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| Category: Opioid Analgesic | ||||||
| 01/23/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Analgesic | ||||||
| 12/14/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Analgesic | ||||||
| 11/10/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Analgesic | ||||||
| 10/05/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 584 | 1,215 | $103,980 | $51,217 |
| 2022 | 9 | 270 | 477 | $57,141 | $25,156 |
| 2021 | 9 | 260 | 1,320 | $85,591 | $38,295 |
| 2020 | 6 | 162 | 296 | $39,115 | $17,265 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 193 | $31,275 | $18,686 | 59.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 86 | 155 | $18,600 | $7,134 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 103 | $11,330 | $6,544 | 57.8% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 47 | 67 | $9,380 | $3,850 | 41.0% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 37 | 48 | $7,840 | $3,652 | 46.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $5,175 | $2,852 | 55.1% |
| 64445 | Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | Office | 2023 | 14 | 17 | $3,600 | $2,243 | 62.3% |
| 64415 | Injection of anesthetic agent and/or steroid into arm nerve bundle (brachial plexus) | Office | 2023 | 14 | 19 | $4,180 | $2,065 | 49.4% |
| 20526 | Injection of carpal tunnel | Office | 2023 | 14 | 26 | $3,510 | $1,844 | 52.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,400 | $1,118 | 46.6% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 11 | 13 | $1,170 | $618.28 | 52.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 106 | 501 | $5,010 | $415.39 | 8.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 21 | 34 | $510.00 | $195.23 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 112 | $20,660 | $10,275 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 86 | $10,927 | $5,930 | 54.3% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 26 | 42 | $7,768 | $3,316 | 42.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,820 | $2,279 | 39.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $4,167 | $1,114 | 26.7% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2022 | 18 | 30 | $2,152 | $1,015 | 47.2% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 15 | 20 | $3,432 | $855.69 | 24.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 26 | 69 | $1,425 | $302.09 | 21.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 13 | 75 | $790.00 | $66.98 | 8.5% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2021 | 14 | 960 | $31,920 | $13,229 | 41.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 111 | $21,530 | $10,363 | 48.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 81 | $10,887 | $5,563 | 51.1% |
About Dr. Jonathon Faber, D.O
Dr. Jonathon Faber, D.O is a Sports Medicine healthcare provider based in Novi, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1700048915.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathon Faber, D.O has received a total of $1,049 in payments from pharmaceutical and medical device companies, with $581.01 received in 2024. These payments were reported across 38 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,049).
As a Medicare-enrolled provider, Faber has provided services to 1,276 Medicare beneficiaries, totaling 3,308 services with total Medicare billing of $131,932. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Sports Medicine, Family Medicine
- Location Novi, MI
- Active Since 06/29/2008
- Last Updated 09/09/2022
- Taxonomy Code 207QS0010X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700048915
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $361.96
- BOTOX (Biological) $187.02
- ZTLido (Drug) $170.30
- UBRELVY (Drug) $70.09
- Belbuca (Drug) $53.34
- Xeomin (Biological) $46.37
- QULIPTA (Drug) $42.00
- ACTIVOS 10 BONE CEMENT (Device) $30.86
- XTAMPZA (Drug) $23.72
- QUTENZA (Drug) $22.60
- AUSTEDO (Drug) $13.92
- INBRIJA (Drug) $13.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.